DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Endroit courant :
>
> This Story


Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

CIVCO Radiotherapy and Adaptiiv ink distribution deal Partnership will increase access to software that personalizes radiotherapy

BWXT to acquire Sotera Health’s Nordion medical isotope business $150M in capital expenditures expected this year

Four ways to attract prospective patients online Helping care seekers get from Google to your facility

With NVIDIA, Canon brings deep learning to its VNA Combining Abierto VNA data with DGX analytics

Physicians should be granted immunity to malpractice lawsuits, says study Recorded a 13 percent decline in adverse events over four years

FDA okays AI-driven device to identify diabetic retinopathy 'A historic moment' toward the future of healthcare

Study finds majority of U.S. radiologists practice as generalists Bringing new clarity to the composition of the imaging workforce

Fujifilm enters the US minimally-invasive surgery market Its new Boston-based business launched new products

Siemens selects SAS IoT analytics to manage data from its global install base Aims to maximize uptime for CT, MR and other systems

Premier Imaging Ventures is now LucidHealth Rebranded to reflect company's vision for the future of radiology

Konica Minolta to acquire Ambry Genetics in $1 billion deal

par Thomas Dworetzky , Contributing Reporter
A Konica Minolta subsidiary is acquiring Aliso Viejo, California's Ambry Genetics in a $1 billion deal, the companies have announced.

The buy will be structured so that Konica Minolta, through Konica Minolta Healthcare Americas – a wholly owned subsidiary of Konica Minolta and Japanese state-backed Innovation Network Corporation of Japan (INCJ) – will pay $800 million to Ambry. Ambry shareholders will get up to $200 million in addition if “certain financial metrics” are met over the next two years, putting the deal's total worth at about $1.0 billion.

Story Continues Below Advertisement

OR Tables, Treatment/GYN/Uro Chairs, Transport Stretchers, Hospital/ICU Bed

iMS combines the superior service of Oakworks Medical and advanced manufacturing technology of FAMED Medical Solutions. The goal of iMS, "Connecting Art and Medical Science" goes way beyond product with exceptional CareLink service. Contact us today!



The deal is set to close in the third quarter of fiscal year 2017.

“This acquisition is the first in a series of strategic initiatives to secure a leading position for Konica Minolta in precision medicine,” Shoei Yamana said in a statement. “The future of medicine is patient-focused. Together with Ambry, we will have the most comprehensive set of diagnostic technologies for mapping an individual’s genetic and biochemical makeup, as well as the capabilities to translate that knowledge into information the medical community can use to discover, prevent, and cost-effectively treat diseases. This will not only serve as the future foundation for our health care business, but will pave the way for a fundamental shift in the way medicine is practiced globally.”

Konica Minolta plans to bring Ambry’s capabilities first to Japan, and then to Europe.

The deal is said to be the biggest ever done by Konica, according to Reuters.

Privately held Ambry was founded in 1999 by President and Chairman Charles L.M. Dunlop and CEO Dr. Aaron Elliott.

The company has a suite of genetic tests for inherited and non-inherited diseases, as well as for numerous clinical specialties, including oncology, cardiology, pulmonology, neurology, and general genetics. The firm has performed more than one million genetic tests and identified more than 45,000 mutations in at least 500 different genes.

“We’re excited by this opportunity to combine both our companies’ technologies to unlock new opportunities for precision medicine,” said Dunlop. “As a part of Konica Minolta, we will have the resources, technology, and scale to advance biomedical research and enable the matching of more patients in more countries with specialized medicines that target the underlying cause of their illness.”

Ambry’s capabilities fit in with Konica Minolta’s imaging technology to provide a “comprehensive range of health care diagnostics,” said the companies.
  Pages: 1 - 2 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Publicité
Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Annuaire
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Les travaux/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Certification Récentes
Voir les utilisateurs récemment certifiés
Evaluation Récentes
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service le forum de techniciens
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2018 DOTmed.com, Inc.
TOUS DROITS RÉSERVÉS